Editorial introductions
Focal therapy of prostate cancer
Active surveillance for prostate cancer
Ultrasound modalities and quantification
Understanding the pathological implications of MRI
In-bore MRI interventions
What tumours should we treat with focal therapy based on risk category, grade, size and location?
Functional outcomes of partial prostate ablation and focal therapy
Opportunities for targeted focal treatment in Japan
Active surveillance for favorable risk prostate cancer
Observational studies and the natural history of screen-detected prostate cancer
Should Gleason 6 be labeled as cancer?
Risk stratification of prostate cancer in the modern era
Identification of candidates for observation
Defining ‘progression’ and triggers for curative intervention during active surveillance
Disease-specific and patient-reported outcomes under active surveillance
Patient and disease factors affecting the choice and adherence to active surveillance
Aligning evidence and practice